HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 575Generated: October 28, 2026
tert-Butyl piperazine-1-carboxylate → HCID 58913155, compound
https://huagongshe.com/reaction/575
Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | tert-Butyl piperazine-1-carboxylate | HCID 143452 | — |
| Reactant | tert-Butyl 7-bromo-1H-indole-1-carboxylate | HCID 26369808 | — |
| Reagent | Cesium carbonate | HCID 10796 | — |
| Catalyst | Palladium (II) acetate | HCID 4144353 | — |
| Catalyst | 2-Dicyclohexylphosphino-2',6'-diisopropoxybiphenyl | HCID 16217985 | — |
| Solvent | 1,4-Dioxane | HCID 31275 | — |
| Product | HCID 58913155 | HCID 58913155 | 0% |
Reaction Steps
_Trial reaction_ Palladium (II) acetate (7.58 mg, 0.03 mmol) and 2-Dicyclohexylphosphino-2',6'-di-i-propoxy-1,1'-biphenyl (31.5 mg, 0.07 mmol) were suspended in 1,4-dioxane (1 mL) at ambient temperature. The mixture was degassed and purged with nitrogen and warmed to 50°C for 20 mins. In a separate vessel, were mixed tert-butyl piperazine-1-carboxylate (62.9 mg, 0.34 mmol), tert-butyl 7-bromo-1H-indole-1-carboxylate (100 mg, 0.34 mmol) and cesium carbonate (165 mg, 0.51 mmol) in 1,4-dioxane (2 mL). The mixture was degassed and purged with nitrogen several times. The catalyst solution was added and the resulting mixture was heated at 95°C overnight under a nitrogen atmosphere. No reaction observed by LCMS. Main component of the mixture was unreacted BOC- protected indole. No loss of BOC, but still no reaction.
Provenance & Evidence
| Source dataset | 750 AstraZeneca ELN dataset |
|---|
| ORD ID | ord-5c1e7b0afe1e4c2ea268d161da8ff7be |
|---|
| Source note | 750 AstraZeneca ELN dataset |
|---|